Form 4: UroGen Pharma Executive Sells Shares
Insider Transaction (Form 4)
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd., sold 60,677 shares of common stock on August 20, 2026 for $47.05 per share.
Summary
- Open-market sale: disposed of 60,677 ordinary shares at $47.05 ($2,854,853) on August 20, 2026; holds 59,086 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,854,853 of stock on the open market.
Insider Transactions
Mark Schoenberg — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Open-market sale | ordinary shares | 60,677 | $47 | $2.9M | 59,086 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Open-market sale (60,677 shares) |
Keywords
insider transaction, Form 4, URGN, UroGen Pharma Ltd., bearish, Mark Schoenberg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.